Insider Selling: Chemed Co. (NYSE:CHE) Director Sells $153,638.32 in Stock

Chemed Co. (NYSE:CHEGet Free Report) Director Patrick P. Grace sold 284 shares of Chemed stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total value of $153,638.32. Following the completion of the transaction, the director now directly owns 3,270 shares in the company, valued at $1,769,004.60. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Chemed Stock Performance

Shares of NYSE:CHE opened at $538.76 on Friday. The company has a market cap of $8.16 billion, a P/E ratio of 29.00, a PEG ratio of 2.22 and a beta of 0.46. Chemed Co. has a one year low of $492.84 and a one year high of $654.62. The business’s 50-day simple moving average is $572.23 and its 200 day simple moving average is $591.40.

Chemed (NYSE:CHEGet Free Report) last announced its earnings results on Wednesday, April 24th. The company reported $4.68 EPS for the quarter, missing the consensus estimate of $5.09 by ($0.41). The company had revenue of $589.23 million for the quarter, compared to analysts’ expectations of $587.18 million. Chemed had a net margin of 12.36% and a return on equity of 30.52%. Analysts predict that Chemed Co. will post 21.54 earnings per share for the current year.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 18th. Investors of record on Thursday, May 30th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, May 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.30%. Chemed’s payout ratio is currently 8.61%.

Institutional Investors Weigh In On Chemed

Several hedge funds and other institutional investors have recently bought and sold shares of the business. DekaBank Deutsche Girozentrale increased its holdings in Chemed by 34.5% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 154,579 shares of the company’s stock worth $98,516,000 after purchasing an additional 39,633 shares during the last quarter. EULAV Asset Management increased its holdings in Chemed by 7.5% during the 1st quarter. EULAV Asset Management now owns 111,399 shares of the company’s stock worth $71,510,000 after purchasing an additional 7,800 shares during the last quarter. Cetera Advisors LLC purchased a new stake in Chemed during the 1st quarter worth approximately $267,000. Second Line Capital LLC increased its holdings in Chemed by 7.1% during the 1st quarter. Second Line Capital LLC now owns 3,648 shares of the company’s stock worth $2,342,000 after purchasing an additional 242 shares during the last quarter. Finally, LRI Investments LLC purchased a new stake in Chemed during the 1st quarter worth approximately $171,000. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on CHE. Oppenheimer lifted their price objective on Chemed from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Thursday, February 29th. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Finally, Royal Bank of Canada reduced their price objective on Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 21st.

View Our Latest Stock Analysis on CHE

Chemed Company Profile

(Get Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Read More

Insider Buying and Selling by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.